Works by Al‐Kali, Aref


Results: 126
    1

    Clinical Outcome and Molecular Profile in Patients with DDX41 Mutation Hot-Spots.

    Published in:
    Hematology Reports, 2025, v. 17, n. 3, p. 26, doi. 10.3390/hematolrep17030026
    By:
    • Toumeh, Nadia;
    • Jabban, Yazan;
    • Nanaa, Ahmad;
    • He, Rong;
    • Viswanatha, David;
    • Jevremovic, Dragan;
    • Foran, James M.;
    • Arana Yi, Cecilia Y.;
    • Saliba, Antoine N.;
    • Hefazi Torghabeh, Mehrdad;
    • Hogan, William J.;
    • Shah, Mithun V.;
    • Mangaonkar, Abhishek A.;
    • Patnaik, Mrinal M.;
    • Alkhateeb, Hassan B.;
    • Al-Kali, Aref
    Publication type:
    Article
    2
    3
    4
    5
    6

    Activity of the oral mitogen-activated protein kinase kinase inhibitor trametinib in RAS-mutant relapsed or refractory myeloid malignancies.

    Published in:
    2016
    By:
    • Borthakur, Gautam;
    • Popplewell, Leslie;
    • Boyiadzis, Michael;
    • Foran, James;
    • Platzbecker, Uwe;
    • Vey, Norbert;
    • Walter, Roland B.;
    • Olin, Rebecca;
    • Raza, Azra;
    • Giagounidis, Aristoteles;
    • Al‐Kali, Aref;
    • Jabbour, Elias;
    • Kadia, Tapan;
    • Garcia‐Manero, Guillermo;
    • Bauman, John W.;
    • Wu, Yuehui;
    • Liu, Yuan;
    • Schramek, Dan;
    • Cox, Donna S.;
    • Wissel, Paul
    Publication type:
    journal article
    7
    8

    Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome.

    Published in:
    British Journal of Haematology, 2025, v. 206, n. 4, p. 1109, doi. 10.1111/bjh.20018
    By:
    • Kusne, Yael;
    • Badar, Talha;
    • Lasho, Terra;
    • Marando, Ludovica;
    • Mangaonkar, Abhishek A.;
    • Finke, Christy;
    • Foran, James M.;
    • Al‐Kali, Aref;
    • Palmer, Jeanne;
    • Arana Yi, Cecilia;
    • Alkhateeb, Hassan B.;
    • Gangat, Naseema;
    • Viswanatha, David;
    • Litzow, Mark R.;
    • Chlon, Timothy;
    • Ferrer, Alejandro;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    9
    10

    Cardiac events in newly diagnosed acute myeloid leukaemia during treatment with venetoclax + hypomethylating agents.

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1232, doi. 10.1111/bjh.19325
    By:
    • Johnson, Isla M.;
    • Karrar, Omer;
    • Rana, Masooma;
    • Iftikhar, Moazah;
    • Chen, Sunny;
    • McCullough, Kristen;
    • Saliba, Antoine N.;
    • Al‐Kali, Aref;
    • Alkhateeb, Hassan;
    • Begna, Kebede;
    • Litzow, Mark;
    • Hogan, William J.;
    • Shah, Mithun;
    • Patnaik, Mrinal M.;
    • Pardanani, Animesh;
    • Hermann, Joerg;
    • Tefferi, Ayalew;
    • Gangat, Naseema
    Publication type:
    Article
    11

    TP53 variant allele frequency and therapy‐related setting independently predict survival in myelodysplastic syndromes with del(5q).

    Published in:
    British Journal of Haematology, 2024, v. 204, n. 4, p. 1243, doi. 10.1111/bjh.19247
    By:
    • Tefferi, Ayalew;
    • Fleti, Farah;
    • Chan, Onyee;
    • Al Ali, Najla H.;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Foran, James M.;
    • Badar, Talha;
    • Khera, Nandita;
    • Shah, Mithun;
    • Hiwase, Devendra;
    • Padron, Eric;
    • Sallman, David A.;
    • Pardanani, Animesh;
    • Arber, Daniel A.;
    • Orazi, Attilio;
    • Reichard, Kaaren K.;
    • He, Rong;
    • Ketterling, Rhett P.;
    • Gangat, Naseema
    Publication type:
    Article
    12
    13

    The clinical and molecular spectrum of ETV6 mutated myeloid neoplasms.

    Published in:
    British Journal of Haematology, 2023, v. 202, n. 2, p. 279, doi. 10.1111/bjh.18850
    By:
    • Gurney, Mark;
    • Chekkaf, Ismahene;
    • Baranwal, Anmol;
    • Basmaci, Rami;
    • Katamesh, Bahga;
    • Greipp, Patricia;
    • Foran, James M.;
    • Badar, Talha;
    • Mangaonkar, Abhishek A.;
    • Begna, Kebede H.;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Shah, Mithun V.;
    • Viswanatha, David S.;
    • He, Rong;
    • Alkhateeb, Hassan B.;
    • Al‐Kali, Aref
    Publication type:
    Article
    14

    Limited activity of fedratinib in myelofibrosis patients relapsed/refractory to ruxolitinib 20 mg twice daily or higher: A real‐world experience.

    Published in:
    British Journal of Haematology, 2022, v. 198, n. 4, p. e54, doi. 10.1111/bjh.18284
    By:
    • Gangat, Naseema;
    • McCullough, Kristen;
    • Al‐Kali, Aref;
    • Begna, Kebede H.;
    • Patnaik, Mrinal M.;
    • Litzow, Mark R.;
    • Hogan, William;
    • Shah, Mithun;
    • Alkhateeb, Hassan;
    • Mangaonkar, Abhishek;
    • Foran, James M.;
    • Palmer, Jeanne M.;
    • Pardanani, Animesh;
    • Tefferi, Ayalew
    Publication type:
    Article
    15
    16

    De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.

    Published in:
    British Journal of Haematology, 2021, v. 195, n. 3, p. 413, doi. 10.1111/bjh.17742
    By:
    • Begna, Kebede H.;
    • Kittur, Jaya;
    • Yui, Jennifer;
    • Gangat, Naseema;
    • Patnaik, Mrinal M.;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • Hogan, William J.;
    • Litzow, Mark R.;
    • Hook, Christopher C.;
    • Wolanskyj, Alexandra P.;
    • Howard, Matthew T.;
    • Hanson, Curtis A.;
    • Ketterling, Rhett P.;
    • Pardanani, Animesh D.;
    • Tefferi, Ayalew
    Publication type:
    Article
    17
    18
    19

    Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 1, p. 211, doi. 10.1007/s00277-022-05016-1
    By:
    • Katamesh, Bahga;
    • Nanaa, Ahmad;
    • He, Rong;
    • Viswanatha, David;
    • Nguyen, Phuong;
    • Greipp, Patricia;
    • Foran, James;
    • Begna, Kebede;
    • Gangat, Naseema;
    • Patnaik, Mrinal;
    • Tefferi, Ayalew;
    • Litzow, Mark;
    • Mangaonkar, Abhishek;
    • Shah, Mithun Vinod;
    • Badar, Talha;
    • Alkhateeb, Hassan B.;
    • Al-Kali, Aref
    Publication type:
    Article
    20

    Autoimmune manifestations in STAG2-mutated myeloid neoplasms.

    Published in:
    Annals of Hematology, 2022, v. 101, n. 12, p. 2785, doi. 10.1007/s00277-022-04995-5
    By:
    • Katamesh, Bahga;
    • Nanaa, Ahmad;
    • He, Rong;
    • Viswanatha, David;
    • Nguyen, Phuong;
    • Greipp, Patricia;
    • Foran, James;
    • Begna, Kebede;
    • Gangat, Naseema;
    • Patnaik, Mrinal;
    • Tefferi, Ayalew;
    • Litzow, Mark;
    • Mangaonkar, Abhishek;
    • Shah, Mithun Vinod;
    • Badar, Talha;
    • Alkhateeb, Hassan B.;
    • Al-Kali, Aref
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27

    Disparities in receiving disease‐directed therapy, allogeneic stem cell transplantation in non‐Hispanic Black patients with TP53‐mutated acute myeloid leukemia.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 6, p. 934, doi. 10.1002/cncr.34604
    By:
    • Badar, Talha;
    • Litzow, Mark R.;
    • Shallis, Rory M.;
    • Patel, Anand;
    • Saliba, Antoine N.;
    • Burkart, Madelyn;
    • Bewersdorf, Jan P.;
    • Stahl, Maximilian;
    • De Camargo Correia, Guilherme Sacchi;
    • Guru Murthy, Guru Subramanian;
    • Abaza, Yasmin;
    • Duvall, Adam;
    • Bradshaw, Danielle;
    • Kota, Vamsi;
    • Dinner, Shira;
    • Goldberg, Aaron D.;
    • Palmisiano, Neil;
    • Al Kali, Aref;
    • Atallah, Ehab
    Publication type:
    Article
    28
    29
    30
    31
    32
    33

    Characteristics of patients with myelodysplastic syndrome with balanced translocations.

    Published in:
    British Journal of Haematology, 2020, v. 190, n. 2, p. 244, doi. 10.1111/bjh.16551
    By:
    • Joshi, Maansi;
    • Greipp, Patricia;
    • Ball, Colleen;
    • Vinod Shah, Mithun;
    • Khurana, Arushi;
    • Yogarajah, Meera;
    • Nguyen, Phuong;
    • He, Rong;
    • Viswanatha, David;
    • Jevremovic, Dragan;
    • Salama, Mohamad;
    • Alkhateeb, Hassan B.;
    • Gangat, Naseema;
    • Patnaik, Mrinal;
    • Begna, Kebede;
    • Hogan, William;
    • Zblewski, Darci;
    • Litzow, Mark;
    • Al‐Kali, Aref
    Publication type:
    Article
    34

    Response to erythropoiesis‐stimulating agents in patients with WHO‐defined myelodysplastic syndrome/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN‐RS‐T).

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 3, p. e104, doi. 10.1111/bjh.16515
    By:
    • Antelo, Guadalupe;
    • Mangaonkar, Abhishek A.;
    • Coltro, Giacomo;
    • Buradkar, Ajinkya;
    • Lasho, Terra L.;
    • Finke, Christy;
    • Carr, Ryan;
    • Binder, Moritz;
    • Gangat, Naseema;
    • Al‐Kali, Aref;
    • Elliott, Michelle A.;
    • King, Rebecca L.;
    • Howard, Matthew;
    • Melody, Megan E.;
    • Hogan, William;
    • Litzow, Mark R;
    • Tefferi, Ayalew;
    • Fernandez‐Zapico, Martin E.;
    • Komrokji, Rami;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45

    U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00922-7
    By:
    • Badar, Talha;
    • Vanegas, Yenny A. Moreno;
    • Nanaa, Ahmad;
    • Foran, James M.;
    • Al-Kali, Aref;
    • Mangaonkar, Abhishek;
    • Murthy, Hemant;
    • Alkhateeb, Hassan B.;
    • Viswanatha, David;
    • He, Rong;
    • Shah, Mithun;
    • Yi, Cecilia Arana;
    • Litzow, Mark R.;
    • Gangat, Naseema;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.
    Publication type:
    Article
    46

    Real-world experience with ponatinib therapy in chronic phase chronic myeloid leukemia: impact of depth of response on survival and prior exposure to nilotinib on arterial occlusive events.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00891-x
    By:
    • Abdelmagid, Maymona G.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Begna, Kebede H.;
    • Hogan, William J.;
    • Patnaik, Mirinal S.;
    • Hashmi, Shahrukh K.;
    • Elliott, Michelle A.;
    • Alkhateeb, Hassan;
    • Karrar, Omer S.;
    • Fleti, Farah;
    • Elnayir, Mohammed H.;
    • Rivera, Candido E.;
    • Murthy, Hemant S.;
    • Foran, James M.;
    • Kharfan-Dabaja, Mohamed A.;
    • Badar, Talha;
    • Viswanatha, David S.;
    • Reichard, Kaaren K.;
    • Gangat, Naseema
    Publication type:
    Article
    47

    TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
    By:
    • Shah, Mithun Vinod;
    • Tran, Elizabeth Ngoc Hoa;
    • Shah, Syed;
    • Chhetri, Rakchha;
    • Baranwal, Anmol;
    • Ladon, Dariusz;
    • Shultz, Carl;
    • Al-Kali, Aref;
    • Brown, Anna L.;
    • Chen, Dong;
    • Scott, Hamish S.;
    • Greipp, Patricia;
    • Thomas, Daniel;
    • Alkhateeb, Hassan B.;
    • Singhal, Deepak;
    • Gangat, Naseema;
    • Kumar, Sharad;
    • Patnaik, Mrinal M.;
    • Hahn, Christopher N.;
    • Kok, Chung Hoow
    Publication type:
    Article
    48

    Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00818-6
    By:
    • Al-Kali, Aref;
    • Nanaa, Ahmad;
    • Viswanatha, David;
    • He, Rong;
    • Nguyen, Phuong;
    • Jevremovic, Dragan;
    • Foran, James M.;
    • Yi, Cecelia Arana;
    • Greipp, Patricia T.;
    • Gangat, Naseema;
    • Patnaik, Mrinal;
    • Tefferi, Ayalew;
    • Litzow, Mark R.;
    • Mangaonkar, Abhishek A.;
    • Shah, Mithun Vinod;
    • Badar, Talha;
    • Alkhateeb, Hassan B.
    Publication type:
    Article
    49

    Abnormal karyotype is an independent predictor of inferior survival in Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN).

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00812-y
    By:
    • Abdallah, Mostafa;
    • McCullough, Kristen;
    • Ilyas, Rimal;
    • Begna, Kebede H.;
    • Al-Kali, Aref;
    • Litzow, Mark R.;
    • Hogan, William J.;
    • Mangaonkar, Abhishek;
    • Alkhateeb, Hassan;
    • Shah, Mithun V.;
    • Elliott, Michelle A.;
    • Foran, James M.;
    • Badar, Talha;
    • Palmer, Jeanne M.;
    • Yi, Cecilia Arana;
    • Sproat, Lisa;
    • Pardanani, Animesh;
    • Patnaik, Mrinal M.;
    • Olteanu, Horatiu;
    • Ketterling, Rhett P.
    Publication type:
    Article
    50

    TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00821-x
    By:
    • Shah, Mithun Vinod;
    • Tran, Elizabeth Ngoc Hoa;
    • Shah, Syed;
    • Chhetri, Rakchha;
    • Baranwal, Anmol;
    • Ladon, Dariusz;
    • Shultz, Carl;
    • Al-Kali, Aref;
    • Brown, Anna L.;
    • Chen, Dong;
    • Scott, Hamish S.;
    • Greipp, Patricia;
    • Thomas, Daniel;
    • Alkhateeb, Hassan B.;
    • Singhal, Deepak;
    • Gangat, Naseema;
    • Kumar, Sharad;
    • Patnaik, Mrinal M.;
    • Hahn, Christopher N.;
    • Kok, Chung Hoow
    Publication type:
    Article